Geneva, March 20 -- International Clinical Trials Registry received information related to the study (NCT07443592) titled 'Treatment for Ph-negative ALL for Adults up to 65 Years' on Feb. 25.

Study Type: Interventional

Study Design: Allocation: Non-Randomized. Intervention model: Parallel Assignment. Primary purpose: Treatment. Masking: None (Open Label).

Primary Sponsor: PETHEMA Foundation

Condition: Acute Lymphoblastic Leukemia

Intervention: Drug: Pediatric-type of chemotherapy (+blinatumomab for B-cell precursor ALL)

Recruitment Status: Not recruiting

Phase: N/A

Date of First Enrollment: March 6, 2026

Target Sample Size: 330

Countries of Recruitment: Spain

To know more, visit https://clinicaltrials.gov/study/NCT074435...